Lv2
198 积分 2023-04-08 加入
GLP-1 receptor agonists
1个月前
已完结
A four-in-one first-in-human study to assess safety, tolerability, pharmacokinetics, pharmacodynamics, and concentration-QTc relationship of HRS-1780, a selective non-steroidal mineralocorticoid receptor antagonist, in healthy men
1个月前
已完结
Results from a Real-World Case Series of Patients with IgAN Who Received at Least 9 Months of Tarpeyo
1个月前
已关闭
PCSK9 inhibition with orally administered NNC0385-0434 in hypercholesterolaemia: a randomised, double-blind, placebo-controlled and active-controlled phase 2 trial
5个月前
已完结
Efficacy and Safety of Oral PCSK9 Inhibitor Enlicitide in Adults With Heterozygous Familial Hypercholesterolemia
5个月前
已完结
A Randomized Phase 2 Trial of Felzartamab in Antibody-Mediated Rejection
6个月前
已完结
Coadministered Cagrilintide and Semaglutide in Adults with Overweight or Obesity
6个月前
已完结
Cagrilintide–Semaglutide in Adults with Overweight or Obesity and Type 2 Diabetes
6个月前
已完结
皖公网安备34019202002308
